… and I served, you know, on their advisory board, looking at all these new, innovative companies that can deliver healthcare cheaper, like telemedicine, that can bring drugs cheaper. You know, Testing in phase one, phase two, and phase three drugs is so expensive. ways to do that more cost effectively that will, you know, help lower drug prices. So there's a lot of innovation out there. (31:54–31:59)
CLAIM
Asserts that drug testing in phases one, two, and three is very costly.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
